BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18846623)

  • 1. Gene symbol: PYGM. Disease: McArdle disease.
    Viéitez I; Teijeira S; Miranda S; San Millán B; Navarro C
    Hum Genet; 2008 Oct; 124(3):300. PubMed ID: 18846623
    [No Abstract]   [Full Text] [Related]  

  • 2. A new rare mutation (691delCC/insAAA) in exon 17 of the PYGM gene causing McArdle disease.
    Quintans B; Sanchez-Andrade A; Teijeira S; Fernandez-Hojas R; Rivas E; López MJ; Navarro C
    Arch Neurol; 2004 Jul; 61(7):1108-10. PubMed ID: 15262743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proposed molecular diagnostic flowchart for myophosphorylase deficiency (McArdle disease) in blood samples from Spanish patients.
    Rubio JC; Garcia-Consuegra I; Nogales-Gadea G; Blazquez A; Cabello A; Lucia A; Andreu AL; Arenas J; Martin MA
    Hum Mutat; 2007 Feb; 28(2):203-4. PubMed ID: 17221871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel nonsense mutation (R269X) in the myophosphorylase gene in a patient with McArdle disease.
    Deschauer M; Opalka JR; Lindner A; Zierz S
    Mol Genet Metab; 2001 Dec; 74(4):489-91. PubMed ID: 11749054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two novel mutations in the myophosphorylase gene in a patient with McArdle disease.
    Deschauer M; Hertel K; Zierz S
    Muscle Nerve; 2003 Jan; 27(1):105-7. PubMed ID: 12508303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mutation in the PYGM gene in a family with pseudo-dominant transmission of McArdle disease.
    Isackson PJ; Tarnopolsky M; Vladutiu GD
    Mol Genet Metab; 2005 Jul; 85(3):239-42. PubMed ID: 15979037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myophosphorylase deficiency].
    Tsujino S
    Ryoikibetsu Shokogun Shirizu; 2001; (36):14-6. PubMed ID: 11596346
    [No Abstract]   [Full Text] [Related]  

  • 8. [Private mutations in the myophosphorylase gene: the first case in a patient of Latin American descent].
    Fernandez-Cadenas I; Nogales-Gadea G; Llige D; Rubio JC; Montaner J; Arenas J; Raspall-Chaure M; Roig-Quilis M; Andreu AL
    Rev Neurol; 2007 Sep 1-15; 45(5):280-3. PubMed ID: 17876739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two novel mutations in the muscle glycogen phosphorylase gene in McArdle's disease.
    Gámez J; Rubio JC; Martín MA; Fernández-Cadenas I; Garcia-Arumi E; Andreu AL; Arenas J
    Muscle Nerve; 2003 Sep; 28(3):380-2. PubMed ID: 12929201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gentamicin treatment in McArdle disease: failure to correct myophosphorylase deficiency.
    Schroers A; Kley RA; Stachon A; Horvath R; Lochmüller H; Zange J; Vorgerd M
    Neurology; 2006 Jan; 66(2):285-6. PubMed ID: 16434679
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular characterization of myophosphorylase deficiency (McArdle disease) in 34 patients from Southern France: identification of 10 new mutations. Absence of genotype-phenotype correlation.
    Aquaron R; Bergé-Lefranc JL; Pellissier JF; Montfort MF; Mayan M; Figarella-Branger D; Coquet M; Serratrice G; Pouget J
    Neuromuscul Disord; 2007 Mar; 17(3):235-41. PubMed ID: 17324573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two new mutations in the myophosphorylase gene in Italian patients with McArdle's disease.
    Bruno C; Lanzillo R; Biedi C; Iadicicco L; Minetti C; Santoro L
    Neuromuscul Disord; 2002 Jun; 12(5):498-500. PubMed ID: 12031624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 144th ENMC International Workshop: Outcome Measures in McArdle Disease, 29 September-1 November 2006, Naarden, The Netherlands.
    Quinlivan R; Vissing J
    Neuromuscul Disord; 2007 Jun; 17(6):494-8. PubMed ID: 17490880
    [No Abstract]   [Full Text] [Related]  

  • 14. Do carriers of PYGM mutations have symptoms of McArdle disease?
    Andersen ST; Dunø M; Schwartz M; Vissing J
    Neurology; 2006 Aug; 67(4):716-8. PubMed ID: 16924035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mutation in the PYGM gene resulting in McArdle disease.
    Rubio JC; Lucia A; Fernández-Cadenas I; Cabello A; Blázquez A; Gámez J; Andreu AL; Martín MA; Arenas J
    Arch Neurol; 2006 Dec; 63(12):1782-4. PubMed ID: 17172620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. McArdle disease: the mutation spectrum of PYGM in a large Italian cohort.
    Bruno C; Cassandrini D; Martinuzzi A; Toscano A; Moggio M; Morandi L; Servidei S; Mongini T; Angelini C; Musumeci O; Comi GP; Lamperti C; Filosto M; Zara F; Minetti C
    Hum Mutat; 2006 Jul; 27(7):718. PubMed ID: 16786513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable presentation of the clinical phenotype of McArdle's disease in a kindred harbouring a novel compound genotype in the muscle glycogen phosphorylase gene.
    Paradas C; Fernandez-Cadenas I; Gallardo E; Lligé D; Arenas J; Illa I; Andreu AL
    Neurosci Lett; 2005 Dec; 391(1-2):28-31. PubMed ID: 16154688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splicing mosaic of the myophosphorylase gene due to a silent mutation in McArdle disease.
    Fernandez-Cadenas I; Andreu AL; Gamez J; Gonzalo R; Martín MA; Rubio JC; Arenas J
    Neurology; 2003 Nov; 61(10):1432-4. PubMed ID: 14638972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotyping glycogen storage disease type II and type V in cattle reared in the Czech Republic.
    Cítek J; Rehout V; Vecerek L; Hájková J
    J Vet Med A Physiol Pathol Clin Med; 2007 Jun; 54(5):257-9. PubMed ID: 17523960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new mutation in the regulatory domain of the myophosphorylase gene affecting protein dimer contact.
    Gamez J; Fernandez R; Bruno C; Andreu AL; Cervera C; Navarro C; Schwartz S; Dimauro S
    Muscle Nerve; 1999 Aug; 22(8):1136-8. PubMed ID: 10417800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.